Apoptosis signaling in tumor therapy

Annals of the New York Academy of Sciences

Volumn 1028, Issue , 2004, Pages 150-156

  Fulda, Simone ^a   Debatin, Klaus Michael ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Apoptosis; Cancer therapy; Resistance

Indexed keywords

CASPASE; DEATH RECEPTOR; FAS ANTIGEN; FLICE INHIBITORY PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; PROTEIN BCL 2; PROTEIN BCL XL; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; CANCER CELL DESTRUCTION; CANCER RESISTANCE; CELL DEATH; CONFERENCE PAPER; CYTOTOXICITY; HUMAN; NONHUMAN; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

EID: 14944384245     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1322.016     Document Type: Conference Paper

References (39)

1. HERR, I. & K.M. DEBATIN. 2001. Cellular stress response and apoptosis in cancer therapy. Blood 98(9): 2603-2614.
2. HENGARTNER, M.O. 2000. The biochemistry of apoptosis. Nature 407(6805): 770-776.
3. RICH, T., R.L. ALLEN & A.H. WYLLIE. 2000. Defying death after DNA damage. Nature 407(6805): 777-783.
4. KARIN, M., Y. CAO, F.R. GRETEN & Z.W. LI. 2002. NF-kappaB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2(4): 301-310.
5. DAVIS, R.J. 2000. Signal transduction by the JNK group of MAP kinases. [See comment.] Cell 103(2): 239-252.
6. THORNBERRY, N.A. & Y. LAZEBNIK. 1998. Caspases: enemies within. Science 281(5381): 1312-1316.
7. IGNEY, F.H. & P.H. KRAMMER. 2002. Death and anti-death: tumour resistance to apoptosis. Nat. Rev. Cancer 2(4): 277-288.
8. LEIST, M. & M. JAATTELA. 2001. Four deaths and a funeral: from caspases to alternative mechanisms. Nat. Rev. Mol. Cell Biol. 2(8): 589-598.
9. NAGATA, S. 2000. Apoptotic DNA fragmentation. Exp. Cell Res. 256(1): 12-18.
10. ASHKENAZI, A. & V.M. DIXIT. 1999. Apoptosis control by death and decoy receptors. Curr. Opin. Cell Biol. 11(2): 255-260.
11. VAN LOO, G., X. SAELENS, M. VAN GURP et al. 2002. The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. Cell Death Differ. 9(10): 1031-1042.
12. FRIESEN, C., S. FULDA & K.M. DEBATIN. 1997. Deficient activation of the CD95 (APO-1/Fas) system in drug-resistant cells. Leukemia 11(11): 1833-1841.
13. FRIESEN, C., I. HERR, P.H. KRAMMER & K.M. DEBATIN. 1996. Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat. Med. 2(5): 574-577.
14. MULLER, M., S. STRAND, H. HUG et al. 1997. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J. Clin. Invest. 99(3): 403-413.
15. FULDA, S., C. FRIESEN & K.M. DEBATIN. 1998. Molecular determinants of apoptosis induced by cytotoxic drugs. Klin. Paediatr. 210(4): 148-152.
16. FULDA, S., M. LOS, C. FRIESEN & K.M. DEBATIN. 1998. Chemosensitivity of solid tumor cells in vitro is related to activation of the CD95 system. Int. J. Cancer 76(1): 105-114.
17. DEBATIN, K.M., D. PONCET & G. KROEMER. 2002. Chemotherapy: targeting the mitochondrial cell death pathway. Oncogene 21(57): 8786-8803.
18. IGNEY, F.H. & P.H. KRAMMER. 2002. Immune escape of tumors: apoptosis resistance and tumor counterattack. J. Leukocyte Biol. 71(6): 907-920.
19. LEBLANC, H.N. & A. ASHKENAZI. 2003. Apo-2L/TRAIL and its death and decoy receptors. Cell Death Differ. 10: 66-75.
20. BAYLIN, S.B. 2002. Mechanisms underlying epigenetically mediated gene silencing in cancer. Semin. Cancer Biol. 12(5): 331-337.
21. VAN NOESEL, M.M., S. VAN BEZOUW, P.A. VOUTE et al. 2003. Clustering of hypermethylated genes in neuroblastoma. Genes Chromosomes Cancer 38(3): 226-233.
22. MAECKER, H.L., Z. YUN, H.T. MAECKER & A.J. GIACCIA. 2002. Epigenetic changes in tumor Fas levels determine immune escape and response to therapy. Cancer Cell 2(2): 139-148.
23. KRUEGER, A., S. BAUMANN, P.H. KRAMMER & S. KIRCHHOFF. 2001. FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis. Mol. Cell. Biol. 21(24): 8247-8254.
24. BARNHART, B.C., J.C. LEE, E.C. ALAPPAT & M.E. PETER. 2003. The death effector domain protein family. Oncogene 22(53): 8634-8644.
25. FULDA, S., E. MEYER & K.M. DEBATIN. 2000. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression. Cancer Res. 60(14): 3947-3956.
26. ZHANG, X.D., A. FRANCO, K. MYERS et al. 1999. Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma. Cancer Res. 59(11): 2747-2753.
27. MANDRUZZATO, S., F. BRASSEUR, G. ANDRY et al. 1997. A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma. J. Exp. Med. 186(5): 785-793.
28. KIM, H., J. LEE, Y. SOUNG et al. 2003. Inactivating mutations of caspase-8 gene in colorectal carcinomas. Gastroenterology 125(3): 708-715.
29. TEITZ, T., T. WEI, M.B. VALENTINE et al. 2000. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat. Med. 6(5): 529-535.
30. FULDA, S., M.U. KUFER, E. MEYER et al. 2001. Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer. Oncogene 20(41): 5865-5877.
31. SALVESEN, G.S. & C.S. DUCKETT. 2002. IAP proteins: blocking the road to death's door. Nat. Rev. Mol. Cell Biol. 3(6): 401-410.
32. ALTIERI, D.C. 2003. Validating survivin as a cancer therapeutic target. Nat. Rev. Cancer 3(1): 46-54.
33. VELCULESCU, V.E., S.L. MADDEN, L. ZHANG et al. 1999. Analysis of human transcriptomes. Nat. Genet. 23(4): 387-388.
34. CORY, S. & J.M. ADAMS. 2002. The Bcl2 family: regulators of the cellular life-or-death switch. Nat. Rev. Cancer 2(9): 647-656.
35. WEI, M.C., W.X. ZONG, E. CHENG et al. 2001. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292(5517): 727-730.
36. CHENG, E.H., M.C. WEI, S. WEILER et al. 2001. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol. Cell 8(3): 705-711.
37. WAJANT, H., K. PFIZENMAIER & P. SCHEURICH. 2002. TNF-related apoptosis inducing ligand (TRAIL) and its receptors in tumor surveillance and cancer therapy. Apoptosis 7: 449-459.
38. WALCZAK, H. & P.H. KRAMMER. 2000. The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp. Cell Res. 256(1): 58-66.
39. OZOREN, N. & W.S. EL-UEIRY. 2003. Cell surface death receptor signaling in normal and cancer cells. Semin. Cancer Biol. 13(2): 135-147.